WBR0855: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
|QuestionAuthor={{MM}} | |QuestionAuthor={{MM}} | ||
|ExamType=USMLE Step 3 | |ExamType=USMLE Step 3 | ||
|SubCategory=Infectious Disease | |||
|SubCategory=Infectious Disease | |SubCategory=Infectious Disease | ||
|SubCategory=Infectious Disease | |||
|SubCategory= | |SubCategory=Infectious Disease | ||
|SubCategory=Infectious Disease | |||
|SubCategory= | |SubCategory=Infectious Disease | ||
|SubCategory=Infectious Disease | |||
|SubCategory=Infectious Disease | |||
|SubCategory=Infectious Disease | |Prompt=A 26 year- old male comes to your office in January complaining of dry cough, headache, sore throat, and feeling of tiredness started yesterday. He mentions a pain all over his body. On examination, the patient is feverish with temperature 39 C (102 F), heart rate 100/min, blood pressure 140/80 mmHg, and respiratory rate of 22/min. What is the best treatment of choice in managing this patient? | ||
|SubCategory=Infectious Disease | |||
|SubCategory= | |||
|SubCategory= | |||
|SubCategory= | |||
|Prompt=A 26 year- old male comes to your office complaining of dry cough, headache, sore throat, and feeling of tiredness started yesterday. He mentions a pain all over his body. On examination, the patient is feverish with temperature 39 C (102 F), heart rate 100/min, blood pressure 140/80 mmHg, and respiratory rate of 22/min. What is the best treatment of choice in managing this patient? | |||
|Explanation=The adamantane drugs (amantadine and rimantadine) are approved for influenza A only, while the neuraminidase inhibitor drugs (zanamivir and oseltamivir) are approved for both influenza A and influenza B, and the recommended to be used when Influenza is the diagnosis if the patient presents within the first 48 hours after the onset of symptoms. In the United States, FDA-approved drugs against influenza are: amantadine, rimantadine, zanamivir (Relenza®), and oseltamivir (Tamiflu®). | |Explanation=The adamantane drugs (amantadine and rimantadine) are approved for influenza A only, while the neuraminidase inhibitor drugs (zanamivir and oseltamivir) are approved for both influenza A and influenza B, and the recommended to be used when Influenza is the diagnosis if the patient presents within the first 48 hours after the onset of symptoms. In the United States, FDA-approved drugs against influenza are: amantadine, rimantadine, zanamivir (Relenza®), and oseltamivir (Tamiflu®). | ||
|AnswerA=Zanamivir | |AnswerA=Zanamivir | ||
Revision as of 15:09, 21 November 2013
| Author | [[PageAuthor::Mohamed Moubarak, M.D. [1]]] |
|---|---|
| Exam Type | ExamType::USMLE Step 3 |
| Main Category | |
| Sub Category | SubCategory::Infectious Disease |
| Prompt | [[Prompt::A 26 year- old male comes to your office in January complaining of dry cough, headache, sore throat, and feeling of tiredness started yesterday. He mentions a pain all over his body. On examination, the patient is feverish with temperature 39 C (102 F), heart rate 100/min, blood pressure 140/80 mmHg, and respiratory rate of 22/min. What is the best treatment of choice in managing this patient?]] |
| Answer A | AnswerA::Zanamivir |
| Answer A Explanation | [[AnswerAExp::Correct
Neuraminidase inhibitor drugs (zanamivir and oseltamivir) are approved for both influenza A and influenza B, and the recommended to be used with Influenza]] |
| Answer B | AnswerB::Amantadine |
| Answer B Explanation | [[AnswerBExp::Incorrect
The adamantane drugs (amantadine and rimantadine) are approved for influenza A only, and shouldn’t be used alone]] |
| Answer C | AnswerC::Rimantadine |
| Answer C Explanation | [[AnswerCExp::Incorrect
The adamantane drugs (amantadine and rimantadine) are approved for influenza A only, and shouldn’t be used alone]] |
| Answer D | AnswerD::Tylenol and follow up |
| Answer D Explanation | [[AnswerDExp::Incorrect
The patient is presented in the first 48 hours after the onset of symptoms, and antiviral therapy is recommended to be used]] |
| Answer E | AnswerE::Reassurance as it is a self limited disease |
| Answer E Explanation | [[AnswerEExp::Incorrect
The patient is presented in the first 48 hours after the onset of influenza symptoms, and antiviral therapy is recommended to be used]] |
| Right Answer | RightAnswer::A |
| Explanation | [[Explanation::The adamantane drugs (amantadine and rimantadine) are approved for influenza A only, while the neuraminidase inhibitor drugs (zanamivir and oseltamivir) are approved for both influenza A and influenza B, and the recommended to be used when Influenza is the diagnosis if the patient presents within the first 48 hours after the onset of symptoms. In the United States, FDA-approved drugs against influenza are: amantadine, rimantadine, zanamivir (Relenza®), and oseltamivir (Tamiflu®). Educational Objective: |
| Approved | Approved::No |
| Keyword | [[WBRKeyword::Influenza]] |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |